OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Est. Return 4.17%
This Quarter Est. Return
1 Year Est. Return
-4.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$58.3M
AUM Growth
-$5.97M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
75
New
Increased
Reduced
Closed

Top Buys

1
+$319K
2
+$288K
3
+$263K
4
NKTR icon
Nektar Therapeutics
NKTR
+$78.4K
5
LGND icon
Ligand Pharmaceuticals
LGND
+$41.8K

Top Sells

1
+$506K
2
+$409K
3
+$408K
4
RUBY
Rubius Therapeutics, Inc
RUBY
+$391K
5
WVE icon
Wave Life Sciences
WVE
+$377K

Sector Composition

1 Healthcare 64.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
51
IQVIA
IQV
$38.4B
$319K 0.47%
1,985
CRL icon
52
Charles River Laboratories
CRL
$8.6B
$300K 0.44%
2,112
GRFS icon
53
Grifois
GRFS
$5.79B
$278K 0.41%
13,196
+114
GILD icon
54
Gilead Sciences
GILD
$154B
$276K 0.41%
4,082
+415
BIIB icon
55
Biogen
BIIB
$26.4B
$263K 0.39%
+1,123
AMGN icon
56
Amgen
AMGN
$182B
$257K 0.38%
1,397
+155
NBIX icon
57
Neurocrine Biosciences
NBIX
$15.2B
$254K 0.38%
3,012
+205
EXEL icon
58
Exelixis
EXEL
$11.6B
$244K 0.36%
11,440
LGND icon
59
Ligand Pharmaceuticals
LGND
$3.84B
$241K 0.36%
3,384
+587
AGIO icon
60
Agios Pharmaceuticals
AGIO
$1.57B
$240K 0.36%
4,806
FGEN icon
61
FibroGen
FGEN
$32.7M
$221K 0.33%
195
+2
SCTL
62
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$115K 0.17%
12,659
ACIU icon
63
AC Immune
ACIU
$279M
– –
-39,801
ALKS icon
64
Alkermes
ALKS
$4.78B
– –
-7,722
CLLS
65
Cellectis
CLLS
$473M
– –
-22,309
CTMX icon
66
CytomX Therapeutics
CTMX
$646M
– –
-25,284
PGEN icon
67
Precigen
PGEN
$1.23B
– –
-32,284
RGNX icon
68
Regenxbio
RGNX
$618M
– –
-8,832
SGMO icon
69
Sangamo Therapeutics
SGMO
$148M
– –
-33,529
SUPN icon
70
Supernus Pharmaceuticals
SUPN
$2.53B
– –
-11,648
UTHR icon
71
United Therapeutics
UTHR
$20.4B
– –
-2,199
WVE icon
72
Wave Life Sciences
WVE
$1.17B
– –
-9,716
XNCR icon
73
Xencor
XNCR
$1.14B
– –
-10,935
SURF
74
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-53,063
RUBY
75
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-21,610
1 2
3